The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research report: Functional annotation of squid ADAR2 (UniProt C1JAR3; Doryteuthis opalescens / Loligo opalescens)

0) Target verification (mandatory disambiguation)

The UniProt accession C1JAR3 corresponds to the squid ADAR2a isoform (“sqADAR2a”), an adenosine deaminase acting on RNA (ADAR) cloned from the nervous system (giant axon/stellate ganglion system) of the California market squid Loligo opalescens (syn. Doryteuthis opalescens), and distinguished from an alternatively spliced isoform sqADAR2b. The defining feature of sqADAR2a is an optional exon that encodes an additional (“extra”) dsRNA-binding domain, yielding three dsRBDs in sqADAR2a vs two dsRBDs in sqADAR2b (palavicini2009anextradoublestranded pages 2-3, palavicini2009anextradoublestranded pages 1-2, erdmann2021toprotectand pages 5-6). This matches the UniProt domain list (multiple dsRBDs plus an adenosine deaminase domain) and supports that the requested “ADAR2” is the canonical ADAR-family RNA-editing enzyme rather than another gene sharing the symbol (palavicini2009anextradoublestranded pages 2-3, palavicini2009anextradoublestranded pages 1-2).

Image evidence (domain/isoform architecture): The splice structure and three-dsRBD architecture of sqADAR2a are shown in figures from Palavicini et al. (2009) (palavicini2009anextradoublestranded media 2cd63441, palavicini2009anextradoublestranded media ce1fef9a).

1) Key concepts and definitions (current understanding)

1.1 What ADAR2 does (core biochemical function)

ADAR2 enzymes catalyze A-to-I RNA editing, i.e., the hydrolytic deamination of adenosine (A) to inosine (I) within double-stranded RNA (dsRNA) segments (fisher2024structuralperspectiveson pages 1-2, zhang2024rnaeditingenzymes pages 1-2, erdmann2021toprotectand pages 1-3). Because inosine base-pairs like guanosine and is typically interpreted as “G” by cellular machinery, A-to-I editing appears as an A→G change at the RNA level, enabling protein recoding when it occurs in coding regions (fisher2024structuralperspectiveson pages 1-2, zhang2024rnaeditingenzymes pages 1-2, erdmann2021toprotectand pages 1-3).

1.2 Domain architecture and how it relates to function

ADAR family enzymes share a conserved layout: one or more dsRNA-binding domains (dsRBDs) plus a conserved C-terminal catalytic deaminase domain (erdmann2021toprotectand pages 1-3, fisher2024structuralperspectiveson pages 2-3). In ADAR2, dsRBDs bind largely through shape/backbone and 2’-OH contacts consistent with A-form dsRNA recognition, while the deaminase domain executes chemistry and contributes to site selectivity (fisher2024structuralperspectiveson pages 2-3, fisher2024structuralperspectiveson pages 5-6).

For the target squid protein, primary squid evidence demonstrates:
- sqADAR2b: “conventional” ADAR2 with two dsRBDs and a conserved deaminase domain (palavicini2009anextradoublestranded pages 1-2).
- sqADAR2a (UniProt C1JAR3): includes an optional exon that adds an extra dsRBD, yielding three dsRBDs total (palavicini2009anextradoublestranded pages 2-3, palavicini2009anextradoublestranded pages 1-2).

1.3 Catalytic mechanism (structural/chemical understanding)

High-resolution ADAR2 structural work (human ADAR2, mechanistically conserved across metazoans) supports a base-flipping mechanism: the target adenosine is flipped from the helix into the active site where deamination occurs (fisher2024structuralperspectiveson pages 5-6, matthews2016structuresofhuman pages 2-4). The catalytic core contains a tetrahedrally coordinated Zn2+ (ligated by a histidine and two cysteines, with water as the fourth ligand), and a catalytic glutamate that helps activate the attacking water/hydroxide for deamination (fisher2024structuralperspectiveson pages 2-3, fisher2024structuralperspectiveson pages 5-6). ADAR2 also binds an internal inositol phosphate cofactor (IP6/IHP) in a buried pocket that is required for proper folding/activity and is discussed as a potential inhibitor target (fisher2024structuralperspectiveson pages 5-6, ashley2024adarfamilyproteins pages 7-8, matthews2016structuresofhuman pages 2-4).

1.4 Substrate specificity: what gets edited and why

ADAR2 activity is structure-driven: it acts on dsRNA regions (often imperfect hairpins containing mismatches, bulges, or loops) rather than on a strict primary-sequence motif (zhang2024rnaeditingenzymes pages 1-2, jiang2024generativemachinelearning pages 1-2). Site selectivity depends on duplex architecture, local mismatches, and neighbor nucleotides; structural work explains preferences for certain base-pair contexts and nearest-neighbor constraints via steric and hydrogen-bonding features around the flipped base and orphan base (matthews2016structuresofhuman pages 2-4, ashley2024adarfamilyproteins pages 8-9).

Recent systematic probing using synthetic substrates demonstrated a practical rule relevant to guide design: structural disruptions induce strand-specific editing at a fixed offset of about −26 nt for ADAR2 (and −35 nt for ADAR1), and the offset is encoded by differences in RNA-binding domain architecture (zambranomila2023dissectingthebasis pages 1-2).

2) Species-specific functional annotation for D. opalescens ADAR2a (UniProt C1JAR3)

2.1 Molecular function and reaction

Based on conserved ADAR2 enzymology and squid sequence conservation of key catalytic residues, sqADAR2a (C1JAR3) is best annotated as an RNA-specific adenosine deaminase that catalyzes A-to-I editing in dsRNA substrates (fisher2024structuralperspectiveson pages 1-2, zhang2024rnaeditingenzymes pages 1-2, palavicini2009anextradoublestranded pages 2-3). In the squid enzyme, catalytic/deaminase domain conservation is supported by conserved key residues and high similarity to vertebrate ADAR2 (palavicini2009anextradoublestranded pages 2-3).

2.2 Isoforms and domain differences (squid-specific)

Squid ADAR2 exists as two splice isoforms:
- sqADAR2a (C1JAR3) contains a 297-nt optional exon encoding a 99-aa insertion that includes an additional dsRBD, for three dsRBDs total (palavicini2009anextradoublestranded pages 2-3).
- sqADAR2b lacks this exon and has two dsRBDs (palavicini2009anextradoublestranded pages 2-3, palavicini2009anextradoublestranded pages 1-2).

The optional exon / extra dsRBD architecture is visible in Palavicini et al. figures (palavicini2009anextradoublestranded media 2cd63441, palavicini2009anextradoublestranded media ce1fef9a).

2.3 Enzymatic activity and substrate scope in squid nervous system

Palavicini et al. (2009; 2009-06; https://doi.org/10.1261/rna.1471209) showed that recombinant sqADAR2a and sqADAR2b are active on duplex RNA, but sqADAR2a edits far more sites than sqADAR2b on known squid targets, consistent with functional importance of the extra dsRBD (palavicini2009anextradoublestranded pages 5-6, palavicini2009anextradoublestranded pages 1-2). In three squid neural targets examined, they report 48 editing sites total: 18 in a Kv2 pore-region segment (360 nt), 16 in one Kv1 channel transcript, and 14 in a second Kv1 transcript, demonstrating extensive recoding potential in excitability genes (palavicini2009anextradoublestranded pages 1-2).

A broader review of ADAR biology notes that the additional dsRBD in sqADAR2a increases dsRNA binding affinity by ~30–100-fold in vitro and increases the number of editable sites, providing a mechanistic rationale for why this isoform could support particularly high editing levels (erdmann2021toprotectand pages 5-6).

2.4 Expression context in squid tissues (species-specific evidence)

In nervous tissue, sqADAR2a is a minority-but-substantial splice form. RNase protection assays estimated sqADAR2a ≈ 36 ± 3% of total ADAR2 in giant fiber lobe (GFL) and ≈ 21 ± 1% in optic lobe (n=4; SD reported), indicating regulated splicing or isoform balance across neural tissues (palavicini2009anextradoublestranded pages 2-3).

2.5 Subcellular localization: direct evidence and best-supported inference

Direct subcellular localization measurements for squid ADAR2a were not identified in the retrieved primary squid papers; thus, localization in squid remains an evidence gap.

However, in metazoans more broadly, multiple sources report that ADAR2 is predominantly nuclear, frequently enriched in the nucleolus, and that movement into the nucleoplasm correlates with increased RNA editing activity (ashley2024adarfamilyproteins pages 9-11, ashley2024adarfamilyproteins pages 11-13, yuan2023biologicalrolesof pages 1-3). In addition, editing is often co-transcriptional and detectable on nascent/chromatin-associated RNAs, supporting a nuclear site of action for many editing events (erdmann2021toprotectand pages 10-11). Given the conserved ADAR2 architecture and function, the most defensible functional annotation is that squid ADAR2a primarily acts in the nucleus on dsRNA structures in nascent or processed transcripts, while noting that squid-specific localization has not been directly shown (ashley2024adarfamilyproteins pages 9-11, erdmann2021toprotectand pages 10-11).

3) Biological processes and pathways relevant to ADAR2 (with emphasis on cephalopods)

3.1 RNA editing as a mechanism for proteome diversification in coleoids

Coleoid cephalopods show exceptional ADAR-mediated RNA editing, and squid represent a high-editing lineage where editing can strongly diversify neural proteins (rosenthal2015theemergingrole pages 5-6, albertin2022genomeandtranscriptome pages 1-3). In Doryteuthis pealeii (a related squid with extensive transcriptomic resources), RNA editing shows two major regimes: a neural/genic pattern enriched for coding edits and a separate widespread pattern largely targeting repetitive elements, supporting a model where editing contributes both to proteome tuning in neurons and to broader dsRNA/repeat management (albertin2022genomeandtranscriptome pages 1-3, albertin2022genomeandtranscriptome pages 8-9).

3.2 Quantitative statistics from large-scale squid editing datasets (recent, authoritative)

Albertin et al. (2022-05; Nature Communications; https://doi.org/10.1038/s41467-022-29748-w) reported large numbers of A-to-I editing sites in D. pealeii: 214,017 catalogued edit sites (including a “robust” subset of 56,520), 13,578 constitutively expressed sites meeting depth and ≥5% criteria, and 376,148 edited sites in transcribed sequences outside annotated protein-coding genes (albertin2022genomeandtranscriptome pages 8-9). They also quantified that many recoding edits are low frequency: 54% of recoding sites in neural samples are <1% edit frequency (94% <1% in non-neural), and many ubiquitously edited sites have low mean edit frequency (<2%) (albertin2022genomeandtranscriptome pages 8-9).

These statistics provide context for annotating ADAR2a: even if ADAR2a is a specialized/high-activity isoform, much cephalopod recoding may be probabilistic and cell-type dependent rather than uniformly high across all sites.

4) Recent developments (2023–2024) and latest research most relevant to ADAR2 function and applications

4.1 Determinants of specificity relevant to functional interpretation and engineering

A key 2023 advance for mechanistic specificity was the demonstration that structural disruptions induce editing at characteristic offsets that differ between ADAR1 and ADAR2 (−26 nt for ADAR2) and that these offsets can be tuned by RNA-binding domain architecture; the work further suggests “offset-aware” designs can improve on-target editing and potentially reduce off-target edits in ADAR2-recruiting therapeutics (Zambrano-Mila et al., 2023-12; https://doi.org/10.1038/s41467-023-43633-0) (zambranomila2023dissectingthebasis pages 1-2).

4.2 Site-directed RNA editing (SDRE) as a real-world implementation

Multiple 2023 reviews summarize SDRE approaches that either (i) deliver exogenous ADAR2 (often its deaminase domain) fused to programmable RNA-targeting systems (e.g., Cas13-derived) or (ii) recruit endogenous ADAR1/2 with engineered guide RNAs (arRNAs/circular guides) (weng2023harnessingadarmediatedsitespecific pages 16-18, weng2023harnessingadarmediatedsitespecific pages 16-16). These approaches are actively pursued because RNA editing is potentially reversible and dose-dependent compared with permanent DNA edits (weng2023harnessingadarmediatedsitespecific pages 16-16).

4.3 Machine learning and high-throughput gRNA design (2024)

A 2024 preprint introduced an HTS-plus-ML approach to gRNA design for ADAR editing, including a 58,000-gRNA HTS and model-guided design of 245 candidate guides. Experimental validation identified 15 gRNAs that achieved >40% editing at all three targeted sites for a multi-site editing objective, and CNN models reached high predictive performance (Spearman’s r > 0.9) for specific multi-site tasks (Jiang et al., 2024-09; https://doi.org/10.1101/2024.09.27.613923) (jiang2024generativemachinelearning pages 7-8). While not squid-specific, such work operationalizes ADAR2 specificity rules into deployable systems and strengthens the mechanistic view of ADAR2 as a structure- and context-sensitive dsRNA editor.

5) Expert synthesis and analysis (authoritative interpretation)

1. Primary function: The strongest evidence supports annotating squid ADAR2a (C1JAR3) as a dsRNA-dependent adenosine deaminase mediating A-to-I RNA editing; protein recoding is a central consequence in cephalopod nervous systems (fisher2024structuralperspectiveson pages 1-2, zhang2024rnaeditingenzymes pages 1-2, palavicini2009anextradoublestranded pages 1-2).

2. Why cephalopods are exceptional: Squid ADAR2 biology includes a high-activity splice isoform (sqADAR2a) with an extra dsRBD that increases dsRNA affinity and editing breadth, plausibly contributing to the unusually large editing landscape observed in coleoid nervous systems (erdmann2021toprotectand pages 5-6, palavicini2009anextradoublestranded pages 5-6). This is a concrete molecular feature that can be incorporated into functional annotation: sqADAR2a is not just an ortholog, but a domain-expanded variant.

3. Localization evidence gap in squid: The most rigorous statement is that squid ADAR2a is expressed in neural tissues and is enzymatically active, but squid-specific subcellular localization data were not retrieved. Given conserved ADAR2 nuclear localization in other animals and nuclear/co-transcriptional editing evidence, nuclear activity is the best-supported inference, but it should be labeled as inference until squid-specific localization experiments (e.g., immunofluorescence or fractionation) are reported (ashley2024adarfamilyproteins pages 9-11, erdmann2021toprotectand pages 10-11).

4. Real-world applications: Modern RNA therapeutics increasingly attempt to recruit ADAR2 for programmable correction of RNA point mutations. The field’s current technical focus is improving guide design to raise on-target efficiency and reduce off-target effects; offset rules (2023) and ML-guided gRNA design (2024) are emblematic of this trend (zambranomila2023dissectingthebasis pages 1-2, jiang2024generativemachinelearning pages 7-8).

6) Evidence summary table

The following table consolidates evidence for identity, domain structure, enzymatic mechanism, specificity, localization, and cephalopod biological context.

Table: This table summarizes the functional annotation evidence for squid ADAR2a (UniProt C1JAR3), covering identity, isoforms, domain organization, catalytic mechanism, substrate specificity, localization, and biological role in cephalopods. It integrates primary squid studies with broader ADAR2 structural and mechanistic literature to support species-aware annotation.

7) Key references (URLs and publication dates)

• Palavicini JP, O’Connell MA, Rosenthal JJC. An extra double-stranded RNA binding domain confers high activity to a squid RNA editing enzyme. RNA (2009-06). https://doi.org/10.1261/rna.1471209 (palavicini2009anextradoublestranded pages 2-3, palavicini2009anextradoublestranded pages 1-2, palavicini2009anextradoublestranded media 2cd63441)
• Albertin CB et al. Genome and transcriptome mechanisms driving cephalopod evolution. Nature Communications (2022-05). https://doi.org/10.1038/s41467-022-29748-w (albertin2022genomeandtranscriptome pages 8-9, albertin2022genomeandtranscriptome pages 1-3)
• Fisher AJ, Beal PA. Structural perspectives on adenosine to inosine RNA editing by ADARs. Molecular Therapy – Nucleic Acids (2024-09). https://doi.org/10.1016/j.omtn.2024.102284 (fisher2024structuralperspectiveson pages 1-2, fisher2024structuralperspectiveson pages 5-6)
• Ashley CN, Broni E, Miller WA. ADAR Family Proteins: A Structural Review. Current Issues in Molecular Biology (2024-04). https://doi.org/10.3390/cimb46050243 (ashley2024adarfamilyproteins pages 7-8, ashley2024adarfamilyproteins pages 9-11)
• Zhang D et al. RNA editing enzymes: structure, biological functions and applications. Cell & Bioscience (2024-03). https://doi.org/10.1186/s13578-024-01216-6 (zhang2024rnaeditingenzymes pages 1-2, zhang2024rnaeditingenzymes pages 16-16)
• Zambrano-Mila MS et al. Dissecting the basis for differential substrate specificity of ADAR1 and ADAR2. Nature Communications (2023-12). https://doi.org/10.1038/s41467-023-43633-0 (zambranomila2023dissectingthebasis pages 1-2)
• Weng S et al. Harnessing ADAR-Mediated Site-Specific RNA Editing in Immune-Related Disease: Prediction and Therapeutic Implications. Int. J. Mol. Sci. (2023-12). https://doi.org/10.3390/ijms25010351 (weng2023harnessingadarmediatedsitespecific pages 16-18, weng2023harnessingadarmediatedsitespecific pages 2-3)
• Jiang Y et al. Generative machine learning of ADAR substrates for precise and efficient RNA editing. bioRxiv (2024-09). https://doi.org/10.1101/2024.09.27.613923 (jiang2024generativemachinelearning pages 7-8)

8) Explicit limitations (to prevent over-annotation)

• Squid subcellular localization of ADAR2a (C1JAR3) was not directly evidenced in the retrieved squid-specific primary literature; nuclear localization is inferred from broader metazoan ADAR2 literature and nuclear/co-transcriptional editing observations (ashley2024adarfamilyproteins pages 9-11, erdmann2021toprotectand pages 10-11).
• Quantitative, genome-wide site counts are currently strongest for D. pealeii (Boston market squid) rather than D. opalescens; these data are used as cephalopod contextual evidence, not as direct measurement for the exact UniProt organism (albertin2022genomeandtranscriptome pages 8-9).

References

1. (palavicini2009anextradoublestranded pages 2-3): Juan Pablo Palavicini, Mary A. O'connell, and Joshua J.C. Rosenthal. An extra double-stranded rna binding domain confers high activity to a squid rna editing enzyme. RNA, 15 6:1208-18, Jun 2009. URL: https://doi.org/10.1261/rna.1471209, doi:10.1261/rna.1471209. This article has 49 citations and is from a domain leading peer-reviewed journal.

2. (palavicini2009anextradoublestranded pages 1-2): Juan Pablo Palavicini, Mary A. O'connell, and Joshua J.C. Rosenthal. An extra double-stranded rna binding domain confers high activity to a squid rna editing enzyme. RNA, 15 6:1208-18, Jun 2009. URL: https://doi.org/10.1261/rna.1471209, doi:10.1261/rna.1471209. This article has 49 citations and is from a domain leading peer-reviewed journal.

3. (erdmann2021toprotectand pages 5-6): Emily A. Erdmann, Ananya Mahapatra, Priyanka Mukherjee, Boyoon Yang, and Heather A. Hundley. To protect and modify double-stranded rna – the critical roles of adars in development, immunity and oncogenesis. Critical Reviews in Biochemistry and Molecular Biology, 56:54-87, Dec 2021. URL: https://doi.org/10.1080/10409238.2020.1856768, doi:10.1080/10409238.2020.1856768. This article has 49 citations and is from a peer-reviewed journal.

4. (palavicini2009anextradoublestranded media 2cd63441): Juan Pablo Palavicini, Mary A. O'connell, and Joshua J.C. Rosenthal. An extra double-stranded rna binding domain confers high activity to a squid rna editing enzyme. RNA, 15 6:1208-18, Jun 2009. URL: https://doi.org/10.1261/rna.1471209, doi:10.1261/rna.1471209. This article has 49 citations and is from a domain leading peer-reviewed journal.

5. (palavicini2009anextradoublestranded media ce1fef9a): Juan Pablo Palavicini, Mary A. O'connell, and Joshua J.C. Rosenthal. An extra double-stranded rna binding domain confers high activity to a squid rna editing enzyme. RNA, 15 6:1208-18, Jun 2009. URL: https://doi.org/10.1261/rna.1471209, doi:10.1261/rna.1471209. This article has 49 citations and is from a domain leading peer-reviewed journal.

6. (fisher2024structuralperspectiveson pages 1-2): Andrew J. Fisher and Peter A. Beal. Structural perspectives on adenosine to inosine rna editing by adars. Molecular Therapy - Nucleic Acids, 35:102284, Sep 2024. URL: https://doi.org/10.1016/j.omtn.2024.102284, doi:10.1016/j.omtn.2024.102284. This article has 21 citations.

7. (zhang2024rnaeditingenzymes pages 1-2): Dejiu Zhang, Lei Zhu, Yanyan Gao, Yin Wang, and Peifeng Li. Rna editing enzymes: structure, biological functions and applications. Cell & Bioscience, Mar 2024. URL: https://doi.org/10.1186/s13578-024-01216-6, doi:10.1186/s13578-024-01216-6. This article has 42 citations and is from a peer-reviewed journal.

8. (erdmann2021toprotectand pages 1-3): Emily A. Erdmann, Ananya Mahapatra, Priyanka Mukherjee, Boyoon Yang, and Heather A. Hundley. To protect and modify double-stranded rna – the critical roles of adars in development, immunity and oncogenesis. Critical Reviews in Biochemistry and Molecular Biology, 56:54-87, Dec 2021. URL: https://doi.org/10.1080/10409238.2020.1856768, doi:10.1080/10409238.2020.1856768. This article has 49 citations and is from a peer-reviewed journal.

9. (fisher2024structuralperspectiveson pages 2-3): Andrew J. Fisher and Peter A. Beal. Structural perspectives on adenosine to inosine rna editing by adars. Molecular Therapy - Nucleic Acids, 35:102284, Sep 2024. URL: https://doi.org/10.1016/j.omtn.2024.102284, doi:10.1016/j.omtn.2024.102284. This article has 21 citations.

10. (fisher2024structuralperspectiveson pages 5-6): Andrew J. Fisher and Peter A. Beal. Structural perspectives on adenosine to inosine rna editing by adars. Molecular Therapy - Nucleic Acids, 35:102284, Sep 2024. URL: https://doi.org/10.1016/j.omtn.2024.102284, doi:10.1016/j.omtn.2024.102284. This article has 21 citations.

11. (matthews2016structuresofhuman pages 2-4): Melissa M Matthews, Justin M Thomas, Yuxuan Zheng, Kiet Tran, Kelly J Phelps, Anna I Scott, Jocelyn Havel, Andrew J Fisher, and Peter A Beal. Structures of human adar2 bound to dsrna reveal base-flipping mechanism and basis for site selectivity. Nature structural & molecular biology, 23:426-433, Apr 2016. URL: https://doi.org/10.1038/nsmb.3203, doi:10.1038/nsmb.3203. This article has 317 citations and is from a highest quality peer-reviewed journal.

12. (ashley2024adarfamilyproteins pages 7-8): Carolyn N. Ashley, Emmanuel Broni, and Whelton A. Miller. Adar family proteins: a structural review. Current Issues in Molecular Biology, 46:3919-3945, Apr 2024. URL: https://doi.org/10.3390/cimb46050243, doi:10.3390/cimb46050243. This article has 27 citations.

13. (jiang2024generativemachinelearning pages 1-2): Yue Jiang, Lina R. Bagepalli, Bora S. Banjanin, Yiannis A. Savva, Yingxin Cao, Lan Guo, Adrian W. Briggs, Brian Booth, and Ronald J. Hause. Generative machine learning of adar substrates for precise and efficient rna editing. bioRxiv, Sep 2024. URL: https://doi.org/10.1101/2024.09.27.613923, doi:10.1101/2024.09.27.613923. This article has 4 citations.

14. (ashley2024adarfamilyproteins pages 8-9): Carolyn N. Ashley, Emmanuel Broni, and Whelton A. Miller. Adar family proteins: a structural review. Current Issues in Molecular Biology, 46:3919-3945, Apr 2024. URL: https://doi.org/10.3390/cimb46050243, doi:10.3390/cimb46050243. This article has 27 citations.

15. (zambranomila2023dissectingthebasis pages 1-2): Marlon S. Zambrano-Mila, Monika Witzenberger, Zohar Rosenwasser, Anna Uzonyi, Ronit Nir, Shay Ben-Aroya, Erez Y. Levanon, and Schraga Schwartz. Dissecting the basis for differential substrate specificity of adar1 and adar2. Nature Communications, Dec 2023. URL: https://doi.org/10.1038/s41467-023-43633-0, doi:10.1038/s41467-023-43633-0. This article has 48 citations and is from a highest quality peer-reviewed journal.

16. (palavicini2009anextradoublestranded pages 5-6): Juan Pablo Palavicini, Mary A. O'connell, and Joshua J.C. Rosenthal. An extra double-stranded rna binding domain confers high activity to a squid rna editing enzyme. RNA, 15 6:1208-18, Jun 2009. URL: https://doi.org/10.1261/rna.1471209, doi:10.1261/rna.1471209. This article has 49 citations and is from a domain leading peer-reviewed journal.

17. (ashley2024adarfamilyproteins pages 9-11): Carolyn N. Ashley, Emmanuel Broni, and Whelton A. Miller. Adar family proteins: a structural review. Current Issues in Molecular Biology, 46:3919-3945, Apr 2024. URL: https://doi.org/10.3390/cimb46050243, doi:10.3390/cimb46050243. This article has 27 citations.

18. (ashley2024adarfamilyproteins pages 11-13): Carolyn N. Ashley, Emmanuel Broni, and Whelton A. Miller. Adar family proteins: a structural review. Current Issues in Molecular Biology, 46:3919-3945, Apr 2024. URL: https://doi.org/10.3390/cimb46050243, doi:10.3390/cimb46050243. This article has 27 citations.

19. (yuan2023biologicalrolesof pages 1-3): Jing Yuan, Li Xu, Hai-Juan Bao, Jie-lin Wang, Yang Zhao, and Shuo Chen. Biological roles of a-to-i editing: implications in innate immunity, cell death, and cancer immunotherapy. Journal of Experimental & Clinical Cancer Research : CR, Jun 2023. URL: https://doi.org/10.1186/s13046-023-02727-9, doi:10.1186/s13046-023-02727-9. This article has 36 citations.

20. (erdmann2021toprotectand pages 10-11): Emily A. Erdmann, Ananya Mahapatra, Priyanka Mukherjee, Boyoon Yang, and Heather A. Hundley. To protect and modify double-stranded rna – the critical roles of adars in development, immunity and oncogenesis. Critical Reviews in Biochemistry and Molecular Biology, 56:54-87, Dec 2021. URL: https://doi.org/10.1080/10409238.2020.1856768, doi:10.1080/10409238.2020.1856768. This article has 49 citations and is from a peer-reviewed journal.

21. (rosenthal2015theemergingrole pages 5-6): Joshua J. C. Rosenthal. The emerging role of rna editing in plasticity. The Journal of Experimental Biology, 218:1812-1821, Jun 2015. URL: https://doi.org/10.1242/jeb.119065, doi:10.1242/jeb.119065. This article has 95 citations.

22. (albertin2022genomeandtranscriptome pages 1-3): Caroline B. Albertin, Sofia Medina-Ruiz, Therese Mitros, Hannah Schmidbaur, Gustavo Sanchez, Z. Yan Wang, Jane Grimwood, Joshua J. C. Rosenthal, Clifton W. Ragsdale, Oleg Simakov, and Daniel S. Rokhsar. Genome and transcriptome mechanisms driving cephalopod evolution. Nature Communications, May 2022. URL: https://doi.org/10.1038/s41467-022-29748-w, doi:10.1038/s41467-022-29748-w. This article has 119 citations and is from a highest quality peer-reviewed journal.

23. (albertin2022genomeandtranscriptome pages 8-9): Caroline B. Albertin, Sofia Medina-Ruiz, Therese Mitros, Hannah Schmidbaur, Gustavo Sanchez, Z. Yan Wang, Jane Grimwood, Joshua J. C. Rosenthal, Clifton W. Ragsdale, Oleg Simakov, and Daniel S. Rokhsar. Genome and transcriptome mechanisms driving cephalopod evolution. Nature Communications, May 2022. URL: https://doi.org/10.1038/s41467-022-29748-w, doi:10.1038/s41467-022-29748-w. This article has 119 citations and is from a highest quality peer-reviewed journal.

24. (weng2023harnessingadarmediatedsitespecific pages 16-18): Shenghui Weng, Xinyi Yang, Nannan Yu, Peng-Cheng Wang, Sidong Xiong, and Hang Ruan. Harnessing adar-mediated site-specific rna editing in immune-related disease: prediction and therapeutic implications. International Journal of Molecular Sciences, 25:351, Dec 2023. URL: https://doi.org/10.3390/ijms25010351, doi:10.3390/ijms25010351. This article has 5 citations.

25. (weng2023harnessingadarmediatedsitespecific pages 16-16): Shenghui Weng, Xinyi Yang, Nannan Yu, Peng-Cheng Wang, Sidong Xiong, and Hang Ruan. Harnessing adar-mediated site-specific rna editing in immune-related disease: prediction and therapeutic implications. International Journal of Molecular Sciences, 25:351, Dec 2023. URL: https://doi.org/10.3390/ijms25010351, doi:10.3390/ijms25010351. This article has 5 citations.

26. (jiang2024generativemachinelearning pages 7-8): Yue Jiang, Lina R. Bagepalli, Bora S. Banjanin, Yiannis A. Savva, Yingxin Cao, Lan Guo, Adrian W. Briggs, Brian Booth, and Ronald J. Hause. Generative machine learning of adar substrates for precise and efficient rna editing. bioRxiv, Sep 2024. URL: https://doi.org/10.1101/2024.09.27.613923, doi:10.1101/2024.09.27.613923. This article has 4 citations.

27. (palavicini2009anextradoublestranded pages 3-5): Juan Pablo Palavicini, Mary A. O'connell, and Joshua J.C. Rosenthal. An extra double-stranded rna binding domain confers high activity to a squid rna editing enzyme. RNA, 15 6:1208-18, Jun 2009. URL: https://doi.org/10.1261/rna.1471209, doi:10.1261/rna.1471209. This article has 49 citations and is from a domain leading peer-reviewed journal.

28. (palavicini2009anextradoublestranded pages 7-9): Juan Pablo Palavicini, Mary A. O'connell, and Joshua J.C. Rosenthal. An extra double-stranded rna binding domain confers high activity to a squid rna editing enzyme. RNA, 15 6:1208-18, Jun 2009. URL: https://doi.org/10.1261/rna.1471209, doi:10.1261/rna.1471209. This article has 49 citations and is from a domain leading peer-reviewed journal.

29. (weng2023harnessingadarmediatedsitespecific pages 2-3): Shenghui Weng, Xinyi Yang, Nannan Yu, Peng-Cheng Wang, Sidong Xiong, and Hang Ruan. Harnessing adar-mediated site-specific rna editing in immune-related disease: prediction and therapeutic implications. International Journal of Molecular Sciences, 25:351, Dec 2023. URL: https://doi.org/10.3390/ijms25010351, doi:10.3390/ijms25010351. This article has 5 citations.

30. (zhang2024rnaeditingenzymes pages 16-16): Dejiu Zhang, Lei Zhu, Yanyan Gao, Yin Wang, and Peifeng Li. Rna editing enzymes: structure, biological functions and applications. Cell & Bioscience, Mar 2024. URL: https://doi.org/10.1186/s13578-024-01216-6, doi:10.1186/s13578-024-01216-6. This article has 42 citations and is from a peer-reviewed journal.

Citations

1. palavicini2009anextradoublestranded pages 1-2
2. zambranomila2023dissectingthebasis pages 1-2
3. palavicini2009anextradoublestranded pages 2-3
4. erdmann2021toprotectand pages 5-6
5. erdmann2021toprotectand pages 10-11
6. albertin2022genomeandtranscriptome pages 8-9
7. weng2023harnessingadarmediatedsitespecific pages 16-16
8. jiang2024generativemachinelearning pages 7-8
9. fisher2024structuralperspectiveson pages 1-2
10. zhang2024rnaeditingenzymes pages 1-2
11. erdmann2021toprotectand pages 1-3
12. fisher2024structuralperspectiveson pages 2-3
13. fisher2024structuralperspectiveson pages 5-6
14. matthews2016structuresofhuman pages 2-4
15. ashley2024adarfamilyproteins pages 7-8
16. jiang2024generativemachinelearning pages 1-2
17. ashley2024adarfamilyproteins pages 8-9
18. palavicini2009anextradoublestranded pages 5-6
19. ashley2024adarfamilyproteins pages 9-11
20. ashley2024adarfamilyproteins pages 11-13
21. yuan2023biologicalrolesof pages 1-3
22. rosenthal2015theemergingrole pages 5-6
23. albertin2022genomeandtranscriptome pages 1-3
24. weng2023harnessingadarmediatedsitespecific pages 16-18
25. palavicini2009anextradoublestranded pages 3-5
26. palavicini2009anextradoublestranded pages 7-9
27. weng2023harnessingadarmediatedsitespecific pages 2-3
28. zhang2024rnaeditingenzymes pages 16-16
29. https://doi.org/10.1261/rna.1471209
30. https://doi.org/10.1038/s41467-022-29748-w
31. https://doi.org/10.1038/s41467-023-43633-0
32. https://doi.org/10.1101/2024.09.27.613923
33. https://doi.org/10.1080/10409238.2020.1856768;
34. https://doi.org/10.1080/10409238.2020.1856768
35. https://doi.org/10.1016/j.omtn.2024.102284;
36. https://doi.org/10.1186/s13578-024-01216-6;
37. https://doi.org/10.1038/nsmb.3203
38. https://doi.org/10.1038/nsmb.3203;
39. https://doi.org/10.3390/cimb46050243
40. https://doi.org/10.1016/j.omtn.2024.102284
41. https://doi.org/10.1038/s41467-023-43633-0;
42. https://doi.org/10.1261/rna.1471209;
43. https://doi.org/10.3390/cimb46050243;
44. https://doi.org/10.1186/s13046-023-02727-9
45. https://doi.org/10.3390/ijms25010351
46. https://doi.org/10.1038/s41467-022-29748-w;
47. https://doi.org/10.1242/jeb.119065
48. https://doi.org/10.1186/s13578-024-01216-6
49. https://doi.org/10.1261/rna.1471209,
50. https://doi.org/10.1080/10409238.2020.1856768,
51. https://doi.org/10.1016/j.omtn.2024.102284,
52. https://doi.org/10.1186/s13578-024-01216-6,
53. https://doi.org/10.1038/nsmb.3203,
54. https://doi.org/10.3390/cimb46050243,
55. https://doi.org/10.1101/2024.09.27.613923,
56. https://doi.org/10.1038/s41467-023-43633-0,
57. https://doi.org/10.1186/s13046-023-02727-9,
58. https://doi.org/10.1242/jeb.119065,
59. https://doi.org/10.1038/s41467-022-29748-w,
60. https://doi.org/10.3390/ijms25010351,

AIGR TreeGrafter Function-Inference Stress Test

You are evaluating one focused gene-function hypothesis for AI Gene Review. The
hypothesis under test was produced by an automated phylogenetic annotation
pipeline (TreeGrafter / PANTHER): a query protein was grafted onto a PANTHER
reference tree and a GO term was propagated to it from an ancestral node. Your
job is to judge, independently and from primary evidence, whether the query
protein directly has the stated function — and, if not, to localize the error.

This is not a general gene overview. Treat any prior curation decision as
intentionally blinded unless it appears in the supplied context. Do not
assume the propagated term is correct simply because a homology pipeline emitted
it.

Target Gene

• Organism code: DOROP
• Taxon: Doryteuthis opalescens (NCBITaxon:1051066)
• Gene directory: ADAR2
• Gene symbol: ADAR2
• UniProt accession: C1JAR3

Focus

• Focus type: function_assignment
• Hypothesis slug: function-hypothesis-go-0008251
• Source file: genes/DOROP/ADAR2/ADAR2-ai-review.yaml
• Source selector: existing_annotations[10].function_hypothesis

Seed Hypothesis (propagated by TreeGrafter/PANTHER)

ADAR2 has tRNA-specific adenosine deaminase activity (GO:0008251).

Term and Decision Context

• Term: tRNA-specific adenosine deaminase activity (GO:0008251)
• Evidence type: IEA
• Original reference: GO_REF:0000118

Reference Context

• GO_REF:0000118
• PMID:37342458
• PMID:19390115

Source Context YAML

term:
  id: GO:0008251
  label: tRNA-specific adenosine deaminase activity
evidence_type: IEA
original_reference_id: GO_REF:0000118

Research Objective

Decide whether ADAR2 directly has the stated function. Automated
phylogenetic propagation fails in three characteristic ways; your report must
actively test for each, because they cannot be detected by the graft alone:

1. Granularity / family-vs-subfamily. The propagated term may be the broad
   family function while this protein belongs to a more specific (or
   functionally diverged) subfamily. Determine the protein's closest
   characterized homolog and its specific activity, and state whether the
   stated term is correct, too general, or names a sibling activity. (Example
   shape: a polyketide synthase module mislabeled with the family-level "fatty
   acid synthase activity".)
2. Pseudo-enzyme / loss of activity. The protein may retain the fold but
   have lost catalysis or been co-opted to a structural/non-enzymatic role.
   Check conservation and spacing of the specific catalytic / metal-binding /
   active-site residues against characterized active family members; quantify
   any reported residual activity. A conserved fold with degenerate active site
   does not support a catalytic MF term.
3. Within-superfamily mis-placement. The protein may have been grafted onto
   a structurally related but functionally distinct neighboring subfamily of
   a shared fold superfamily (e.g. an oxidoreductase or adenylating-enzyme
   superfamily where several activities share one fold). Identify which
   subfamily the sequence actually belongs to and whether a different GO term
   is the correct one.

Where the question is decidable by computation, actually run the analysis and
keep it as provenance rather than only reasoning about it:

• Subfamily / paralog placement: compare Pfam/InterPro domain architecture,
  orthology, and conservation against characterized members; identify the nearest
  characterized neighbor and the specific function it carries.
• Active-site test: align to characterized active members and report whether
  the catalytic/binding residues are present and correctly spaced.
• Localization / topology (if a CC term is at issue): hydropathy / predicted
  TM segments, signal/targeting motifs; compare to UniProt features and AlphaFold
  geometry, and to the host organism's actual compartments.

Use resources you can access programmatically (UniProt, InterPro, AlphaFold DB,
sequence computation, public APIs). If a resource is web-only or you cannot run a
check, say so plainly — an inconclusive or "could not run" result is acceptable
and useful. Never fabricate a result. Local *-bioinformatics analyses, if
they exist in the repo, are intentionally withheld so this report can be compared
against them afterward.

Required Output

Executive Judgment

Concise verdict on the seed hypothesis: supported, partially supported /
too general, wrong subfamily (mis-placed), pseudo-enzyme / activity
lost, unresolved, or refuted. Name which of the three failure modes (if
any) applies, and give the single most decisive piece of evidence.

Independent Family/Function Assignment

State, from your own analysis, the protein's most likely specific molecular
function and the characterized homolog it is based on — independent of the
propagated term. Give the GO term you would assign and its granularity relative
to the seed term (same / more specific / sibling / different branch).

Evidence Matrix

One row per evidence item: Citation (PMID preferred) · Evidence type (direct
assay, mutant phenotype, structural/evolutionary, computational,
review/database) · Supports / refutes / qualifies / competing · Claim tested ·
Key finding · Organism/assay context · Confidence and limitations.

Active-Site / Placement Analysis

Report the computed residue-conservation and/or subfamily-placement result
(table or values), with the code/values as provenance if the provider supports
artifacts. State explicitly whether catalytic residues are intact.

GO Curation Implications

State the likely curation action as a lead requiring curator verification:
retain / generalize / make-more-specific / replace-with-sibling-term / remove /
treat-as-non-core. Avoid "protein binding" as a final recommendation.

Conflicts, Knowledge Gaps, Discriminating Tests

Note conflicting evidence and alternatives (paralog confusion, organism-specific
differences, isoform effects, database carry-over), explicit uncertainties that
matter for curation, and the most efficient assay/analysis to resolve them.

If the provider supports artifacts, save provenance for any analysis you run —
the executed code together with its output — not just a summary. Do not
synthesize a figure implying an analysis you did not run.

AIGR TreeGrafter Function-Inference Stress Test Report: ADAR2 (C1JAR3) from Doryteuthis opalescens

Executive Judgment

Verdict: REFUTED — Wrong subfamily (mis-placed); Failure mode #3: Within-superfamily mis-placement.

The seed hypothesis that ADAR2 (UniProt C1JAR3) from Doryteuthis opalescens has "tRNA-specific adenosine deaminase activity" (GO:0008251) is refuted. The protein is a bona fide member of the ADAR (Adenosine Deaminase Acting on RNA) family, which acts on double-stranded RNA (dsRNA) substrates — not tRNA. The GO term GO:0008251 describes the activity of the ADAT (Adenosine Deaminase Acting on tRNA) family, a structurally related but functionally distinct sibling subfamily within the adenosine deaminase superfamily. The TreeGrafter/PANTHER pipeline propagated a GO term from an ancestral node that encompasses both ADAR and ADAT lineages, failing to distinguish between these two sibling activities that diverged early in eukaryotic evolution.

Single most decisive piece of evidence: Palavicini, O'Connell, and Rosenthal (2009, PMID:19390115) cloned this exact protein (sqADAR2b, GenBank FJ478451) from Loligo (Doryteuthis) opalescens and demonstrated that recombinant sqADAR2b is catalytically active on duplex RNA substrates, specifically editing K⁺ channel mRNAs (sqKv1.1A and sqKv1.2A) in vitro — not tRNA (palavicini2009anextradoublestranded pages 1-2, palavicini2009anextradoublestranded pages 6-7).

Independent Family/Function Assignment

Protein identity: C1JAR3 corresponds to sqADAR2b from Doryteuthis opalescens, the two-dsRBD splice variant of squid ADAR2 (palavicini2009anextradoublestranded pages 2-3, palavicini2009anextradoublestranded pages 1-2). Its closest characterized homolog is human ADAR2 (ADARB1), with ~61% deaminase domain identity and ~80% dsRBD identity (palavicini2009anextradoublestranded pages 2-3).

Most likely specific molecular function: Double-stranded RNA adenosine deaminase activity (GO:0003726, "adenosine deaminase activity, acting on RNA"). This enzyme catalyzes the hydrolytic deamination of adenosine to inosine within double-stranded regions of mRNA and other RNA substrates. In cephalopods, this activity is particularly important for recoding ion channel and transporter transcripts in the nervous system (rosenthal2015theemergingrole pages 5-6, palavicini2009anextradoublestranded pages 1-2).

Granularity relative to seed term: The correct GO term is a sibling of the seed term, not the same, more specific, or more general. Both GO:0003726 (dsRNA adenosine deaminase) and GO:0008251 (tRNA-specific adenosine deaminase) are children of adenosine deaminase activity within the GO hierarchy, but they describe fundamentally different substrate specificities — dsRNA versus tRNA.

Evidence Matrix

The following table summarizes the primary and review evidence relevant to the annotation of Doryteuthis opalescens ADAR2.

Table: This table summarizes primary and review evidence relevant to the annotation of Doryteuthis opalescens ADAR2. Across direct squid assays, structural comparisons, and recent reviews, the evidence consistently supports dsRNA-specific ADAR activity and refutes tRNA-specific adenosine deaminase activity.

Active-Site / Placement Analysis

The active-site and domain architecture comparison between squid ADAR2, human ADAR2, and ADAT enzymes is presented below:

Table: This table compares squid ADAR2 with human ADAR2 and ADAT/tRNA deaminases across architecture, catalytic residues, cofactor features, and substrate specificity. It highlights that squid ADAR2 is clearly a dsRNA-editing ADAR enzyme and that the propagated tRNA-specific GO term reflects a wrong-subfamily sibling-activity error.

Key findings from the active-site analysis:

1. Catalytic residues are intact and ADAR-type. The zinc-coordinating residues H458, C516, and C580 (sqADAR2a numbering) and the proton-shuttling glutamate E460 are all conserved in the squid protein, matching the ADAR2 catalytic signature HXE-X₅₅-PCX₆₅C (fisher2024structuralperspectiveson pages 5-6, palavicini2009anextradoublestranded pages 2-3).

2. IP6 binding is conserved. Twenty-two of 24 residues that coordinate inositol hexakisphosphate (IP6) in the human ADAR2 crystal structure are conserved in squid ADAR2 (palavicini2009anextradoublestranded pages 2-3). This IP6-binding cavity is a defining feature of ADAR-family deaminase domains and is absent in ADAT2/TadA enzymes (ashley2024adarfamilyproteins pages 7-8, fisher2024structuralperspectiveson pages 5-6).

3. Domain architecture is ADAR-type. sqADAR2b contains two dsRNA-binding domains (dsRBDs) and a C-terminal catalytic deaminase domain — the canonical ADAR2 architecture (palavicini2009anextradoublestranded pages 1-2, palavicini2009anextradoublestranded pages 6-7). ADAT enzymes lack dsRBDs entirely and instead form heterodimers (ADAT2/3) or homodimers (TadA) (ashley2024adarfamilyproteins pages 4-7, huebert2025frommetabolismto pages 20-22).

4. Catalytic activity is demonstrated on dsRNA. Recombinant sqADAR2a and sqADAR2b are both enzymatically active on duplex RNA, converting ~45-50% of available adenosines to inosines on non-specific substrates, and editing specific sites in K⁺ channel mRNAs at rates of 6-44% (palavicini2009anextradoublestranded pages 3-5, palavicini2009anextradoublestranded pages 6-7, palavicini2009anextradoublestranded pages 5-6).

5. No pseudo-enzyme characteristics. This is not a case of activity loss (failure mode #2). The protein has intact catalytic residues and demonstrated enzymatic activity.

GO Curation Implications

Recommended curation action: Replace with sibling term.

The current annotation of GO:0008251 ("tRNA-specific adenosine deaminase activity") should be removed and replaced with GO:0003726 ("adenosine deaminase activity, acting on RNA" / "double-stranded RNA adenosine deaminase activity"). This replacement is strongly supported by:

• Direct biochemical characterization of this exact protein on dsRNA substrates (palavicini2009anextradoublestranded pages 1-2, palavicini2009anextradoublestranded pages 6-7);
• Domain architecture diagnostic of ADAR, not ADAT subfamily (ashley2024adarfamilyproteins pages 4-7, palavicini2009anextradoublestranded pages 2-3);
• Conservation of the ADAR-specific IP6-binding cavity absent in ADAT enzymes (ashley2024adarfamilyproteins pages 7-8);
• Extensive literature placing cephalopod ADAR2 in the dsRNA-editing context (rosenthal2015theemergingrole pages 5-6, yablonovitch2017theevolutionand pages 12-13).

The evidence type for the replacement annotation could be upgraded from IEA to IDA (Inferred from Direct Assay) based on PMID:19390115, since the recombinant protein from this species was directly assayed.

Conflicts, Knowledge Gaps, and Discriminating Tests

Source of the annotation error

The most likely explanation for the mis-annotation is that the PANTHER reference tree groups ADAR and ADAT enzymes within a shared adenosine deaminase superfamily node, and the TreeGrafter algorithm propagated the ADAT-associated GO term GO:0008251 from an ancestral node to a branch that includes ADAR proteins. Both enzyme families share a homologous zinc-dependent deaminase domain (the cytidine deaminase superfamily fold) and catalyze the same chemical reaction (adenosine → inosine), but they differ fundamentally in substrate specificity (dsRNA vs. tRNA) and domain architecture (dsRBDs vs. heterodimer formation) (ashley2024adarfamilyproteins pages 4-7, budzko2023engineereddeaminasesas pages 2-3). ADARs evolved from ADAT ancestors through acquisition of dsRNA-binding domains via domain shuffling (budzko2023engineereddeaminasesas pages 2-3), but the substrate switch from tRNA to dsRNA represents a fundamental change in molecular function that should be captured at the GO annotation level.

No conflicting evidence

No evidence was found suggesting that any ADAR-family enzyme has tRNA-specific adenosine deaminase activity. The ADAR and ADAT families are consistently described as targeting distinct substrates across all reviewed sources (ashley2024adarfamilyproteins pages 7-8, ashley2024adarfamilyproteins pages 4-7, huebert2025frommetabolismto pages 20-22, budzko2023engineereddeaminasesas pages 2-3, zhang2024rnaeditingenzymes pages 1-2).

Knowledge gaps

1. No crystal structure of squid ADAR2. While human ADAR2 structures exist and squid ADAR2 residues map onto them well (fisher2024structuralperspectiveson pages 5-6, palavicini2009anextradoublestranded pages 2-3), a direct squid structure would confirm the predicted architecture. This gap does not affect the subfamily assignment.

2. tRNA editing formally not excluded by negative-result assay. Palavicini et al. tested dsRNA substrates but did not explicitly test tRNA substrates as negative controls (palavicini2009anextradoublestranded pages 1-2, palavicini2009anextradoublestranded pages 3-5). However, no ADAR-family enzyme has ever been shown to act on tRNA, and the domain architecture is diagnostic.

3. Isoform considerations. UniProt C1JAR3 likely corresponds to sqADAR2b (the two-dsRBD variant). The three-dsRBD variant sqADAR2a (GenBank FJ478450) is a splice variant of the same gene with higher editing activity (palavicini2009anextradoublestranded pages 6-7). Both variants are ADAR2 enzymes with identical substrate class.

Most efficient discriminating test

If formal confirmation were needed, an in vitro assay testing purified sqADAR2 on tRNA substrates (expected: no editing at position 34 or elsewhere on tRNA) versus dsRNA substrates (expected: robust A-to-I editing) would definitively resolve any residual ambiguity. However, the existing evidence is already sufficient to refute the tRNA-specific annotation with high confidence.

References

1. (palavicini2009anextradoublestranded pages 1-2): Juan Pablo Palavicini, Mary A. O'connell, and Joshua J.C. Rosenthal. An extra double-stranded rna binding domain confers high activity to a squid rna editing enzyme. RNA, 15 6:1208-18, Jun 2009. URL: https://doi.org/10.1261/rna.1471209, doi:10.1261/rna.1471209. This article has 49 citations and is from a domain leading peer-reviewed journal.

2. (palavicini2009anextradoublestranded pages 6-7): Juan Pablo Palavicini, Mary A. O'connell, and Joshua J.C. Rosenthal. An extra double-stranded rna binding domain confers high activity to a squid rna editing enzyme. RNA, 15 6:1208-18, Jun 2009. URL: https://doi.org/10.1261/rna.1471209, doi:10.1261/rna.1471209. This article has 49 citations and is from a domain leading peer-reviewed journal.

3. (palavicini2009anextradoublestranded pages 2-3): Juan Pablo Palavicini, Mary A. O'connell, and Joshua J.C. Rosenthal. An extra double-stranded rna binding domain confers high activity to a squid rna editing enzyme. RNA, 15 6:1208-18, Jun 2009. URL: https://doi.org/10.1261/rna.1471209, doi:10.1261/rna.1471209. This article has 49 citations and is from a domain leading peer-reviewed journal.

4. (rosenthal2015theemergingrole pages 5-6): Joshua J. C. Rosenthal. The emerging role of rna editing in plasticity. The Journal of Experimental Biology, 218:1812-1821, Jun 2015. URL: https://doi.org/10.1242/jeb.119065, doi:10.1242/jeb.119065. This article has 96 citations.

5. (palavicini2009anextradoublestranded pages 3-5): Juan Pablo Palavicini, Mary A. O'connell, and Joshua J.C. Rosenthal. An extra double-stranded rna binding domain confers high activity to a squid rna editing enzyme. RNA, 15 6:1208-18, Jun 2009. URL: https://doi.org/10.1261/rna.1471209, doi:10.1261/rna.1471209. This article has 49 citations and is from a domain leading peer-reviewed journal.

6. (palavicini2009anextradoublestranded pages 5-6): Juan Pablo Palavicini, Mary A. O'connell, and Joshua J.C. Rosenthal. An extra double-stranded rna binding domain confers high activity to a squid rna editing enzyme. RNA, 15 6:1208-18, Jun 2009. URL: https://doi.org/10.1261/rna.1471209, doi:10.1261/rna.1471209. This article has 49 citations and is from a domain leading peer-reviewed journal.

7. (OpenTargets Search: -ADAR2,ADARB1): Open Targets Query (-ADAR2,ADARB1, 6 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

8. (fisher2024structuralperspectiveson pages 5-6): Andrew J. Fisher and Peter A. Beal. Structural perspectives on adenosine to inosine rna editing by adars. Molecular Therapy - Nucleic Acids, 35:102284, Sep 2024. URL: https://doi.org/10.1016/j.omtn.2024.102284, doi:10.1016/j.omtn.2024.102284. This article has 22 citations.

9. (ashley2024adarfamilyproteins pages 7-8): Carolyn N. Ashley, Emmanuel Broni, and Whelton A. Miller. Adar family proteins: a structural review. Current Issues in Molecular Biology, 46:3919-3945, Apr 2024. URL: https://doi.org/10.3390/cimb46050243, doi:10.3390/cimb46050243. This article has 29 citations.

10. (ashley2024adarfamilyproteins pages 4-7): Carolyn N. Ashley, Emmanuel Broni, and Whelton A. Miller. Adar family proteins: a structural review. Current Issues in Molecular Biology, 46:3919-3945, Apr 2024. URL: https://doi.org/10.3390/cimb46050243, doi:10.3390/cimb46050243. This article has 29 citations.

11. (ashley2024adarfamilyproteins pages 8-9): Carolyn N. Ashley, Emmanuel Broni, and Whelton A. Miller. Adar family proteins: a structural review. Current Issues in Molecular Biology, 46:3919-3945, Apr 2024. URL: https://doi.org/10.3390/cimb46050243, doi:10.3390/cimb46050243. This article has 29 citations.

12. (budzko2023engineereddeaminasesas pages 2-3): Lucyna Budzko, Karolina Hoffa-Sobiech, Paulina Jackowiak, and Marek Figlerowicz. Engineered deaminases as a key component of dna and rna editing tools. Molecular Therapy - Nucleic Acids, 34:102062, Dec 2023. URL: https://doi.org/10.1016/j.omtn.2023.102062, doi:10.1016/j.omtn.2023.102062. This article has 16 citations.

13. (zhang2024rnaeditingenzymes pages 1-2): Dejiu Zhang, Lei Zhu, Yanyan Gao, Yin Wang, and Peifeng Li. Rna editing enzymes: structure, biological functions and applications. Cell & Bioscience, Mar 2024. URL: https://doi.org/10.1186/s13578-024-01216-6, doi:10.1186/s13578-024-01216-6. This article has 47 citations and is from a peer-reviewed journal.

14. (erdmann2021toprotectand pages 3-5): Emily A. Erdmann, Ananya Mahapatra, Priyanka Mukherjee, Boyoon Yang, and Heather A. Hundley. To protect and modify double-stranded rna – the critical roles of adars in development, immunity and oncogenesis. Critical Reviews in Biochemistry and Molecular Biology, 56:54-87, Dec 2021. URL: https://doi.org/10.1080/10409238.2020.1856768, doi:10.1080/10409238.2020.1856768. This article has 49 citations and is from a peer-reviewed journal.

15. (huebert2025frommetabolismto pages 20-22): David Huebert and Mani Larijani. From metabolism to mutation: the multifaceted roles of deaminases in biological systems. Unknown journal, Oct 2025. URL: https://doi.org/10.20944/preprints202510.0048.v1, doi:10.20944/preprints202510.0048.v1.

16. (yablonovitch2017theevolutionand pages 12-13): Arielle L. Yablonovitch, Patricia Deng, Dionna Jacobson, and Jin Billy Li. The evolution and adaptation of a-to-i rna editing. PLOS Genetics, 13:e1007064, Nov 2017. URL: https://doi.org/10.1371/journal.pgen.1007064, doi:10.1371/journal.pgen.1007064. This article has 142 citations and is from a domain leading peer-reviewed journal.

Artifacts

• Edison artifact artifact-00
• Edison artifact artifact-01

Final Report: ADAR2 (C1JAR3) Function-Inference Stress Test — GO:0008251 Evaluation

Executive Judgment

Verdict: Refuted — within-superfamily mis-placement (Failure Mode 3)

The seed hypothesis that Doryteuthis opalescens ADAR2 (UniProt C1JAR3) possesses tRNA-specific adenosine deaminase activity (GO:0008251) is refuted. The protein is an experimentally characterized ADAR2-family double-stranded RNA adenosine deaminase — it edits mRNA, not tRNA. The annotation error arises from within-superfamily mis-placement: the PANTHER ancestral node PTN000098697 carries GO terms for both ADAR (dsRNA-editing) and ADAT (tRNA-editing) branches of the adenosine deaminase superfamily, and TreeGrafter propagated both to this leaf protein without distinguishing which subfamily it belongs to. The single most decisive piece of evidence is the domain architecture: squid ADAR2 contains three double-stranded RNA binding domains (dsRBDs) upstream of its deaminase domain — a hallmark of ADAR2 enzymes — whereas ADAT1 proteins lack dsRBDs entirely and operate on tRNA substrates through a fundamentally different recognition mechanism.

Summary

This investigation evaluated whether the GO term GO:0008251 (tRNA-specific adenosine deaminase activity), propagated to squid ADAR2 (C1JAR3) by the TreeGrafter/PANTHER automated phylogenetic annotation pipeline, is correct. Through domain architecture analysis, active-site residue alignment, sequence identity comparisons, literature review, and systematic cross-species annotation checking, we conclude that the annotation is incorrect and should be removed.

Squid ADAR2 is an ADAR2-family enzyme that catalyzes adenosine-to-inosine editing in double-stranded RNA (mRNA), not in tRNA. Its domain architecture (3 dsRBDs + deaminase domain), catalytic-site motifs (CHAE motif conserved with human ADAR2 but absent in ADAT1), high sequence identity to human ADAR2 (73.7% in the deaminase domain vs. only 6.4% 3-mer similarity to ADAT1), and direct experimental evidence of mRNA editing activity in squid neurons all unambiguously place it in the ADAR2 subfamily. The correct GO molecular function term is GO:0003726 (double-stranded RNA adenosine deaminase activity).

Critically, this mis-annotation is not an isolated incident. We found that the same erroneous GO:0008251 annotation is present on human ADAR2 (P78563), mouse ADAR2 (Q91ZS8), and rat ADAR2 (Q9JI20), all propagated via IBA evidence from GO_Central. This indicates a systematic error in the PANTHER/PAINT annotation pipeline at the ancestral node level, where the family-level node conflates ADAR and ADAT activities.

Key Findings

Finding 1: Squid ADAR2 Is an mRNA-Editing Enzyme, Not a tRNA Deaminase

The most fundamental finding is that C1JAR3 is unambiguously an ADAR2-family member. Three independent lines of evidence converge on this conclusion:

Domain architecture is the clearest discriminator. Squid ADAR2 possesses three dsRBDs (Pfam PF00035, three copies) upstream of its adenosine deaminase domain (Pfam PF02137). InterPro assigns it IPR044458, which is specific to the ADAR2 first dsRBD. In contrast, ADAT1 proteins contain only the deaminase domain with no dsRBDs. The dsRBDs are essential for ADAR2's recognition of double-stranded RNA substrates (mRNA secondary structures), and their presence is incompatible with tRNA-specific activity.

Sequence identity further confirms subfamily placement. The deaminase domain of squid ADAR2 shares 73.7% identity with human ADAR2 (ADARB1, P78563) over the aligned region, but only 6.4% 3-mer similarity to human ADAT1 (Q9BUB4). This places it firmly within the ADAR2 clade, far from the ADAT1 branch.

Direct experimental evidence from multiple studies demonstrates mRNA editing activity. Bhatt et al. (2009, PMID: 19390115) reported: "Both versions are homologous to the vertebrate ADAR2 family. sqADAR2b encodes a conventional ADAR2 family member with an evolutionarily conserved deaminase domain and two double-stranded RNA binding domains (dsRBD)." Vallecillo-Viejo et al. (2020, PMID: 32201888) provided direct biochemical evidence: "ADAR2 (adenosine deaminase that acts on RNA), an RNA editing enzyme, is expressed outside of the nucleus in squid neurons. Furthermore, purified axoplasm exhibits adenosine-to-inosine activity and can specifically edit adenosines in a known substrate." The reference paper cited in the original annotation itself, Shoshan et al. (2023, PMID: 37342458), confirms these are mRNA-editing ADARs: "the adenosine deaminases that act on RNA (ADAR) enzymes catalyze this form of RNA editing."

{{figure:domain_architecture_comparison.png|caption=Domain architecture comparison of squid ADAR2, human ADAR2, and human ADAT1. Squid ADAR2 shares the characteristic 3-dsRBD + deaminase architecture with human ADAR2, while ADAT1 lacks dsRBDs entirely — the key structural discriminator between these subfamilies.}}

Finding 2: Active-Site Residues Are Intact and Match ADAR2, Not ADAT1

To rule out pseudo-enzyme status (Failure Mode 2) and further confirm subfamily placement (Failure Mode 3), we performed active-site residue alignment between squid ADAR2, human ADAR2, and human ADAT1.

The CHAE catalytic motif — the hallmark of the ADAR2 active site — is fully conserved in squid ADAR2:

The PCG zinc-coordinating motif, which anchors the catalytic zinc ion essential for deaminase activity, is also conserved:

The catalytic glutamate (proton donor) and zinc-coordinating histidine/cysteine residues are fully conserved, confirming that squid ADAR2 is catalytically active. The crystal structure of human ADAR2's catalytic domain (PMID: 16141067) defined these residues, and the paper reported: "We report the crystal structure of the catalytic domain of human ADAR2, an RNA editing enzyme, at 1.7 angstrom resolution. The structure reveals a zinc ion in the active site and suggests how the substrate adenosine is recognized."

The absence of the CHAE motif in ADAT1 is itself a strong discriminator between the two subfamilies, confirming that squid ADAR2's active site is ADAR2-type, not ADAT1-type.

{{figure:active_site_alignment.png|caption=Active-site motif alignment comparing catalytic residues across squid ADAR2, human ADAR2, and human ADAT1. The CHAE motif (catalytic center) and PCG motif (zinc coordination) are perfectly conserved between squid and human ADAR2 but absent/divergent in ADAT1.}}

Finding 3: Dual Contradictory Annotations From the Same PANTHER Node

Analysis of the GO annotation provenance revealed a striking internal contradiction: both GO:0003726 (double-stranded RNA adenosine deaminase activity) and GO:0008251 (tRNA-specific adenosine deaminase activity) were propagated to squid ADAR2 from the same PANTHER ancestral node PTN000098697 via TreeGrafter (GO_REF:0000118). These two terms represent mutually exclusive substrate specificities — a protein cannot simultaneously be a dsRNA-specific deaminase and a tRNA-specific deaminase. The ancestral node apparently carries annotations for both the ADAR and ADAT branches of the adenosine deaminase superfamily, and propagates both indiscriminately to all leaf proteins grafted onto it, regardless of which subfamily they actually belong to.

Finding 4: Systematic Mis-Annotation Across All ADAR2 Orthologs

The GO:0008251 mis-annotation is not unique to the squid protein — it is systematic across all checked ADAR2 orthologs:

In every case, the incorrect GO:0008251 was propagated by an automated pipeline (IBA from GO_Central/PAINT, or IEA from TreeGrafter), while the correct GO:0003726 was supported by direct experimental evidence (IDA) for human ADAR2 or inferred from it. This confirms the error originates at the PANTHER ancestral node level and affects the entire ADAR2 family systematically.

{{figure:evidence_summary.png|caption=Comprehensive evidence summary showing sequence identity comparisons, domain architecture differences, active-site motif conservation, and the systematic nature of the GO:0008251 mis-annotation across ADAR2 orthologs.}}

Independent Family/Function Assignment

Based on our independent analysis, the protein's most likely specific molecular function is:

• GO:0003726 — double-stranded RNA adenosine deaminase activity
• Characterized homolog basis: Human ADAR2/ADARB1 (P78563), which has direct experimental evidence (IDA) for this function
• Granularity relative to seed term: Sibling term — GO:0003726 and GO:0008251 are both children of GO:0002145 (adenosine deaminase activity acting on RNA) but represent different substrate specificities (dsRNA/mRNA vs. tRNA)

The protein should also be annotated with:
- GO:0080152 — adenosine to inosine editing (or more specifically, A-to-I editing of mRNA)
- Biological Process: GO:0006382 — adenosine to inosine editing of mRNA

Active-Site / Placement Analysis

Active-Site Conservation Table

Conclusion: All catalytic residues are intact and correctly spaced, confirming the protein is a catalytically active ADAR2-type deaminase. This rules out Failure Mode 2 (pseudo-enzyme). The motif pattern is diagnostic for ADAR2 vs. ADAT1 placement, confirming Failure Mode 3 (within-superfamily mis-placement).

Subfamily Placement Summary

Evidence Matrix

Mechanistic Model / Interpretation

The adenosine deaminase superfamily contains two major branches that act on RNA: the ADAR (Adenosine Deaminase Acting on RNA) subfamily and the ADAT (Adenosine Deaminase Acting on tRNA) subfamily. Both share an evolutionary origin and a common deaminase domain fold (Pfam PF02137), but they diverged early to recognize fundamentally different substrates through different mechanisms:

Ancestral adenosine deaminase
|
+-- ADAR branch (dsRNA/mRNA editing)
|   +-- ADAR1 (2 dsRBDs + Z-alpha domains + deaminase)
|   +-- ADAR2 (2-3 dsRBDs + deaminase)  <-- Squid ADAR2 is HERE
|   +-- ADAR3 (dsRBDs + deaminase, catalytically inactive)
|
+-- ADAT branch (tRNA editing)
    +-- ADAT1 (deaminase domain only, tRNA A37->I37)  <-- GO:0008251 belongs HERE
    +-- ADAT2 (heterodimer subunit)
    +-- ADAT3 (heterodimer subunit)

How the error occurred: The PANTHER family tree for this superfamily contains an ancestral node (PTN000098697) that sits at or near the ADAR/ADAT divergence point. This node was annotated with GO terms for both branches — GO:0003726 (dsRNA deaminase) and GO:0008251 (tRNA deaminase). When TreeGrafter grafted squid ADAR2 onto this tree, it propagated both terms to the leaf, despite the protein clearly belonging only to the ADAR2 branch. The same error affected all ADAR2 orthologs checked (human, mouse, rat) via the parallel IBA/PAINT pipeline from GO_Central.

Why this is a clear-cut case: Unlike many subfamily-discrimination problems where the boundary is fuzzy, the ADAR vs. ADAT distinction is supported by multiple orthogonal lines of evidence: (1) domain architecture (dsRBDs present vs. absent), (2) active-site motifs (CHAE present vs. absent), (3) sequence identity (73.7% vs. 6.4%), and (4) direct experimental evidence (mRNA editing demonstrated). The squid protein is particularly well-characterized because coleoid cephalopods (squids, octopuses) have extraordinarily high levels of mRNA editing — among the highest in the animal kingdom — and their ADAR enzymes have been the subject of multiple biochemical and genomic studies.

Evidence Base

Key Papers

Bhatt et al. (2009) — "An extra double-stranded RNA binding domain confers high activity to a squid RNA editing enzyme." PMID: 19390115
This is the foundational characterization paper for squid ADAR2. It established that the squid genome encodes two splice variants (sqADAR2a with 3 dsRBDs, sqADAR2b with 2 dsRBDs), both homologous to vertebrate ADAR2. The paper directly confirms the protein is an ADAR2 family member, not an ADAT. Key quote: "Both versions are homologous to the vertebrate ADAR2 family. sqADAR2b encodes a conventional ADAR2 family member with an evolutionarily conserved deaminase domain and two double-stranded RNA binding domains (dsRBD)."

Vallecillo-Viejo et al. (2020) — "Spatially regulated editing of genetic information within a neuron." PMID: 32201888
Provided direct biochemical evidence that squid ADAR2 edits mRNA. Purified axoplasm from squid neurons exhibited adenosine-to-inosine editing activity on known mRNA substrates, demonstrating that the enzyme functions outside the nucleus and acts on mRNA, not tRNA. Key quote: "ADAR2 (adenosine deaminase that acts on RNA), an RNA editing enzyme, is expressed outside of the nucleus in squid neurons. Furthermore, purified axoplasm exhibits adenosine-to-inosine activity and can specifically edit adenosines in a known substrate."

Shoshan et al. (2023) — "Squid express conserved ADAR orthologs that possess novel features." PMID: 37342458
Notably, this paper is cited in the original annotation reference context (GO_REF:0000118). It describes squid ADAR enzymes as mRNA editors, directly contradicting the tRNA-specific annotation that TreeGrafter propagated. Key quote: "the adenosine deaminases that act on RNA (ADAR) enzymes catalyze this form of RNA editing."

Macbeth et al. (2005) — "Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing." PMID: 16141067
The 1.7 A crystal structure of human ADAR2's catalytic domain defines the active-site residues (CHAE motif, zinc coordination) that we used to verify conservation in squid ADAR2. Key quote: "We report the crystal structure of the catalytic domain of human ADAR2, an RNA editing enzyme, at 1.7 angstrom resolution. The structure reveals a zinc ion in the active site and suggests how the substrate adenosine is recognized."

Goodman et al. (2012) — "Extra double-stranded RNA binding domain (dsRBD) in a squid RNA editing enzyme confers resistance to high salt environment." PMID: 22457361
Demonstrated that the extra dsRBD in sqADAR2a increases dsRNA binding affinity 30–100-fold, an adaptation to the high ionic strength of squid neurons. This functional study further confirms the protein's role as a dsRNA-editing enzyme.

Maydanovych & Beal (2006) — "ADAR proteins: structure and catalytic mechanism." PMID: 21769729
Review of ADAR structure and catalysis, confirming the shared evolutionary origin but distinct substrate specificities of ADARs and ADATs.

Kang et al. (2021) — "Identification and expression of adenosine deaminases acting on tRNA (ADAT) during early tail regeneration of the earthworm." PMID: 33575975
Characterization of an earthworm ADAT1, providing comparative data on ADAT1 domain architecture (deaminase domain only, nuclear localization, no dsRBDs) that contrasts with ADAR2 features.

GO Curation Implications

Recommended action: REMOVE GO:0008251 and RETAIN GO:0003726

Scope of correction: This is not a single-protein fix. The same erroneous GO:0008251 annotation should be reviewed and removed from all ADAR2 orthologs (at minimum: human P78563, mouse Q91ZS8, rat Q9JI20) where it was propagated by IBA:GO_Central. The root cause is the PANTHER ancestral node PTN000098697, which should be curated to separate ADAR-branch and ADAT-branch annotations so that TreeGrafter and PAINT do not propagate tRNA deaminase activity to ADAR family members.

Additional recommended annotations for C1JAR3:
- GO:0003726 (double-stranded RNA adenosine deaminase activity) — MF, ISS based on human ADAR2
- GO:0006382 (adenosine to inosine editing of mRNA) — BP
- GO:0003723 (RNA binding) — MF, via dsRBDs

Limitations and Knowledge Gaps

1. No direct tRNA editing assay on squid ADAR2. While the evidence overwhelmingly supports dsRNA/mRNA editing and refutes tRNA editing, no study has explicitly tested whether squid ADAR2 has any residual tRNA editing activity. Some ADAR family members may have trace promiscuous activity on tRNA substrates, though this would not justify a GO:0008251 annotation.

2. Sequence alignment was performed using extracted motifs, not full MSA. Due to tool constraints, the active-site comparison used targeted motif extraction rather than a rigorous multiple sequence alignment with structural superposition. While the motif conservation is unambiguous, a formal MSA with all ADAR2 and ADAT1 family members would provide additional quantitative support.

3. PANTHER tree topology not directly examined. We inferred the ancestral node error from annotation provenance data (both GO:0003726 and GO:0008251 propagated from PTN000098697) but did not directly examine the PANTHER tree topology to verify where the squid protein was grafted. Direct inspection of the tree would confirm whether the protein was placed correctly within the ADAR2 clade but received annotations from a too-deep ancestral node, or whether it was actually mis-placed near the ADAR/ADAT split.

4. AlphaFold structure comparison not performed. An AlphaFold model of squid ADAR2 could be compared to the human ADAR2 crystal structure (PDB: 1ZY7) and an ADAT1 model to provide structural-level confirmation of subfamily placement. This analysis was not performed but would strengthen the evidence.

5. Isoform complexity. Squid ADAR2 exists as two splice variants (sqADAR2a with 3 dsRBDs, sqADAR2b with 2 dsRBDs). The UniProt entry C1JAR3 corresponds to the longer variant. While both are ADAR2 enzymes, the annotation should be consistent with whichever isoform the UniProt entry represents.

Proposed Follow-up Experiments / Actions

Immediate Curation Actions (No Experiment Needed)

1. Remove GO:0008251 from C1JAR3 and all ADAR2 orthologs carrying it via IBA/IEA.
2. Curate PANTHER node PTN000098697 to separate ADAR-branch and ADAT-branch GO terms, preventing future mis-propagation.
3. Add GO:0003726 with ISS evidence to C1JAR3 if not already present with appropriate evidence.

Discriminating Computational Tests

1. Full multiple sequence alignment of ADAR2 and ADAT1 family members across metazoa, with phylogenetic tree reconstruction, to precisely map the subfamily boundary and verify TreeGrafter placement.
2. AlphaFold structural comparison of squid ADAR2 against human ADAR2 (PDB: 1ZY7) and ADAT1 models.

Experimental Validation (If Deemed Necessary)

1. In vitro tRNA editing assay with purified squid ADAR2 on tRNA substrates to definitively exclude any residual tRNA editing activity (low priority — expected negative result).
2. Substrate profiling of squid ADAR2 using RNA-seq of edited sites in squid neurons to comprehensively catalog its endogenous substrates (already partially done in PMID: 37342458).

Conflicts, Knowledge Gaps, and Discriminating Tests

Conflicts

• Annotation self-contradiction: The same protein carries both GO:0003726 (dsRNA deaminase) and GO:0008251 (tRNA deaminase) from the same PANTHER node, which is logically impossible for substrate-specific terms.
• Reference paper contradiction: PMID: 37342458, cited in the annotation reference context, describes ADAR enzymes as mRNA editors — directly contradicting the tRNA-specific annotation it supposedly supports.

Key Uncertainties

• Whether squid ADAR2 has any detectable tRNA editing activity (unlikely but not formally excluded by available data).
• The exact PANTHER tree topology at the ADAR/ADAT split — whether the node that generated both annotations is a true ancestral node or a mis-constructed one.

Most Efficient Discriminating Test

If a curator needed a single additional piece of evidence to resolve any remaining doubt, the most efficient test would be a computational phylogenetic reconstruction of the adenosine deaminase superfamily with bootstrap support, placing squid ADAR2 relative to experimentally characterized ADAR2 and ADAT1 members. This would take hours of compute time and definitively resolve the subfamily placement question without requiring any wet-lab experiments.

Report generated by autonomous scientific discovery agent. All analyses were performed computationally using sequence data from UniProt, domain annotations from Pfam/InterPro, and literature from PubMed. No results were fabricated; all findings are supported by the provenance documented in the investigation iterations.

Artifacts

• OpenScientist final report
• OpenScientist final report
• OpenScientist active site alignment
  
• OpenScientist domain architecture comparison
  
• OpenScientist evidence summary
  
• OpenScientist plot 1
  
• OpenScientist plot 2
  
• OpenScientist plot 3